The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target is a research paper published in Pharmacological Reviews (2022). On theSindex it has a DataRank of 0. It has been cited 86 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NHLBI NIH HHS
Grant: R01 HL136595
Science and Technology Facilities Council
Grant: ST/R002754/1
NIDDK NIH HHS
Grant: R01 DK117495
NHLBI NIH HHS
Grant: R01 HL128189
Novo Nordisk Fonden
Grant: NNF19OC0058592
NIDDK NIH HHS
Grant: R01 DK061578
National Institutes of Health
Grant: 5R01HL128189-02
Renal AT2 Receptors in Hypertension
National Institutes of Health
Grant: 1R01DK117495-01
Protective Arm of the Renin Angiotensin System in Obese Kidney
National Institutes of Health
Grant: 5R01HL136595-04
Neurons expressing angiotensin type 2 receptors in the NTS as an access point for cardiovascular control.
National Institutes of Health
Grant: 1R01DK061578-01A1
Renal Angiotensin ll Receptor Function in Obesity
FWCI
10.61
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals